Diatech 2025 ERDF Regional Programme 2021/2027 Project
Diatech Pharmacogenetics is pleased to announce its participation in the Regional Call for “PROMOZIONE DI INVESTIMENTI PRODUTTIVI NELLE MARCHE” with the project DIATECH 2025, which includes investments aimed at expanding the company’s market presence and increasing the range of products offered. The call was issued by the Marche Region under PR MARCHE ERDF 2021/2027 – […]
Diatech Pharmacogenetics will attend the next “10° Congresso Triennale di Anatomia Patologica SIAPeC-IAP”
Diatech Pharmacogenetics is pleased to announce its participation in the 10th Triennial Congress of Pathological Anatomy (SIAPeC-IAP). This congress is an important opportunity to meet pathologists and laboratory professionals, exchange knowledge on molecular pathology and precision diagnostics, and showcase our latest solutions for pharmacogenetics and patient-centered diagnostic workflows. Where: Quark Hotel, Via Lampedusa, Milan (venue […]
Diatech Pharmacogenetics will attend the ESPT Congress in Rotterdam
From 5 to 8 November, you can find us exhibiting at De Doelen in Rotterdam!
Join our upcoming webinar: “Unlocking Precision Medicine: The Critical Role of BRCA 1-2 Molecular Testing”
Date: Thursday, September 25th Time: 3:30 PM (CEST); Duration 40 minutes Place: Online Platform Speaker: Dr. Maria Scatolini,PhD – Head, Molecular Oncology Laboratory Edo ed Elvo Tempia Foundation, Biella (Italy) We are pleased to invite you to this new educational series presented by Diatech Pharmacogenetics, in collaboration with leading professionals in the field of molecular diagnostics. Our goal is to […]
Diatech Pharmacogenetics will attend the 38th European Congress of Pathology
From 6 to 10 September, the 38th edition of the European Congress of Pathology will be held at the Austria Center in Vienna. We look forward to seeing you at stand no. 70, in room X5. Don’t miss the Meet the Expert event organised in collaboration with Johnson & Johnson, “Unlocking molecular testing in bladder […]
Diatech Pharmacogenetics will join the European Society of Human Genetics Congress 2025
Join Us from Saturday 24th to Monday 26th Booth n. 450 Allianz MiCo, Milan
Shooting Cancer Highlights – UGT1A1 & DPYD: Safer chemotherapy starts with genotyping
DPYD Genotyping in Fluoropyrimidine Therapy: Reducing Toxicity, Improving Outcome Fluoropyrimidines such as 5-fluorouracil (5-FU), capecitabine, and tegafur are widely used in oncology, treating over 3.5 million patients annually—with 600,000 in Europe alone. Despite their effectiveness, these drugs carry a significant risk of toxicity: 10–40% of patients develop severe side effects (Grade 3–4) requiring hospitalisation and […]
Advancing Precision Medicine: Preventing ADRs with Pharmacogenomic Panel Testing
Drug response is highly variable between individuals. This interindividual variability response to medication, which contributes to adverse drug reactions (ADRs), is mainly due to interaction between genetic variants and medications (1). ADRs are estimated to be between the fourth and sixth most common cause of death worldwide, entering in the list of other prevalent causes […]
Diatech Pharmacogenetics will attend the SEAP-IAP 2025 Congess
We are excited to share that Diatech Pharmacogenetics will be attending the 32nd National Congress of SEAP-IAP From May 23 to May 25 2025 Palacio de Congresos y Auditorio Kursaal, San Sebastiàn, Spain
Diatech Pharmacogenetics will exhibit at Medlab-Middle East from February 3 to 6 in Dubai
Diatech Pharmacogenetics will exhibit at Medlab, a landmark event in the Middle East highlighting cutting-edge advances and sustainable practices in laboratory medicine. Visit us at stand Z6C51 from 3 to 6 February 2025!